Methods of treating SLE with anti-OX40L antibodies
US10654935B2 · kind B2 · utility
4Cited by
18References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 1, 2016 |
| Grant date | May 19, 2020 |
| Priority date | — |
| Expiry date | Jan 9, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to anti-human OX40L antibodies, new medical uses and methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.